Try it
Pharmacology · Chemotherapy: nitrosoureas
Sample itemA man with glioblastoma receives a lipid-soluble alkylating agent that crosses the blood-brain barrier. Four to six weeks later his counts fall, and after cumulative dosing he develops pulmonary fibrosis. Which drug is it?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Carmustine
Carmustine and lomustine are nitrosoureas that are highly lipophilic and cross into the CNS, so they are used in brain tumours. They cause delayed and prolonged myelosuppression and dose-related pulmonary fibrosis. The other alkylators are less lipid soluble and do not cause this pattern.
Option by option
A. Carmustine (correct)
Correct. A lipophilic nitrosourea with delayed myelosuppression and pulmonary fibrosis.
B. Chlorambucil
Chlorambucil is used in chronic lymphocytic leukaemia and does not cause this pattern.
C. Cyclophosphamide
Cyclophosphamide is a prodrug causing haemorrhagic cystitis and does not enter the brain well.
D. Melphalan
Melphalan is used in myeloma and does not cross the blood-brain barrier appreciably.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?